SKY Clinical Research Network Group

Studies

Studies

Our Current Studies

Join the Rapidly Growing Industry of Clinical Trials and Make a Difference in Medical Research!

Clinical trials are vital research studies that determine the safety and effectiveness of medical strategies, treatments, and devices for humans. They help identify the most effective approaches for specific illnesses or groups of people. 

By participating in clinical research, investigators in private practice can contribute to medical knowledge, advance patient care, and benefit the medical/biotechnology industry. 

Phase III: Weight Loss (AMG133)

  • Over the age of 18

  • Must have a BMI greater than 30

  • Must not be on any other weight loss medication

  • Willing to self-inject medication subcutaneously

Phase II: Type II Diabetes (Carmot)

  • 18 and older

  • must have an A1C of 7.0 or higher

  • Must have be on metformin alone or metformin with a SGLT2 or diet and exercise

  • must have an A1C of at least 7.0 or higher

Phase IIA: Weight Loss (Pfizer C4551010)

  • 18 and older

  • BMI of < 30 or BMI of < 27 with prior health conditions

  • at least one unsuccessful attempt to lose body weight

  • Must be willing to take an injectable and an oral medication

Phase III: Childhood Migraine (H8H-MC-LAHV)

  • 6-18 Years Old

  • History of Migraine Attacks

  • Migraines that last longer than 3 hours

  • at least 2-8 migraines per month prior to the start of the study

Phase II: Pneumococcal Vaccine (Pfizer)

  • 12-15 months

  • Must have received at least 3 doses of Prevnar20

Phase II/III: Chronic Kidney disease (Vertex)

  • 12 to 65 years of age

  • Must be diagnosed with Chronic Kidney Disease

  • Must have the APOL-1 biomarker

Phase II: Type II Disease (J1R-MC-GZFD)

  • Over the age of 18

  • Must be diagnosed with type II Diabetes

  • Must be taking semaglutide or tirzepatide